Gynecologic Cancer
PRINCIPAL INVESTIGATORS
- Marta Gil Martin
- David Llobet Navàs
- Mireia Martín Satué
- Beatriz Pardo Búrdalo
- Jordi Ponce i Sebastià
- Ruth Rodríguez Barrueco
CLINICAL RESEARCHERS
- Maria Dolores Marti Cardona
Marc Barahona Orpinell
POSTDOCTORAL RESEARCHERS
- Nuria Bonifaci Cano
- Laura Devis Jauregui
- Mireia Olivan Riera
- Susanna Marín i Borràs
PREDOCTORAL RESEARCHERS
- Laura Coll Iglesias
- Katja Gassner
- Esther Guerra Fernández
- Aitor Rodriguez Martinez
- Maria Del Rosario Taco Sanchez
- Carla Trapero Candela
- August Vidal I Bel
SCIENTIFIC SUPPORT
- Francisco Javier Llobet Navàs
- Axel Rodriguez Vazquez
- Ricard Bonilla Amadeo
Cancer
Oncobell
Scientific production
41
PAPERS
Average IF: 9,394
7
LED PAPERS
Average IF: 6,689
9 PUBLICATIONS IN FIRST DECILE
25 PUBLICATIONS IN FIRST QUARTILE
29 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Herzog,C;Marín,F;Jones,A;Evans,I;Reisel,D;Redl,E;Schreiberhuber,L et al, A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets., J. Clin. Oncol., 2022;40(33):3828-doi:10.1200/JCO.22.00266
- Jiménez,C;Antonelli,R;Nadal Ribelles,M;Devis Jauregui,L; Latorre,P; Solé,C; Masanas,M et al, Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program., Mol. Cancer, 2022;21(1):175-175, doi:10.1186/s12943-022-01643-4
- Muelas Fernandez,M;Lerida Urteaga,A;Paules Villar,MJ;Vidal Bel,A;Ruiz Pombo,M, Strongyloides hyperinfection in a patient from Venezuela with lower gastrointestinal bleeding., J. Travel Med., 2022;29(1):doi:10.1093/jtm/taab084
- Rodríguez Barrueco,R;Latorre,J;Devis Jáuregui,L; Lluch,A; Bonifaci,N;Llobet, FJ; livan,M et al, A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG., Adv. Sci., 2022;9(4):doi:10.1002/advs.202104759
- Pané Foix,M;Fernandez Calvo,D;Condom Mundó,I;Suarez Novo,JF;Merino Serra,E; Garcia Benett,JR; Gomà Gàllego,M et al, Clinical relevance of amyloid in prostate samples: a report on 40 patients., Histopathology, 2022;81(3):363-370, doi:10.1111/his.14717
Research highlights
PROJECTS
1 Granted competitive project
11 Ongoing competitive projects
9 Started clinical trials
30 Ongoing clinical trials
PUBLISHED WORKS
1 Thesis
1 Clinical guideline
Selected projects
- 17ACL120. A PHASE IA/B OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARACOKINETICS OF MTIG7192A AS A SINGLE AGENT AND INCOMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC TUMORS. Genentech, Inc. Budget: 619866. 2017-2026. PI: Gil Martin, Marta.
- 19PSJ014. TARGETING THE AUTORESISTOME AS A NEW THERAPEUTIC STRATEGY IN ENDOMETRIAL CANCER. Asociación Española Contra el Cáncer (AECC). Budget: 299849,22. 2019-2023. PI: Llobet Navàs, David.
- 17ACL048. ESTUDIO DE FASE IB, ABIERTO Y MULTICÉNTRICO, PARA CARACTERIZAR LA SEGURIDAD, TOLERABILIDAD Y FARMACODINÁMICA (PD) DE PDR001 EN COMBINACIÓN CON CJM112, EGF816, ILARIS (CANAKINUMAB) O MEKINIST (TRAMETINIB). Budget: 283580. 2017- . PI: Gil Martin, Marta.
- 18ACL156. ESTUDIO DE FASE I, ABIERTO, MULTICÉNTRICO, DE BÚSQUEDA DE DOSIS DE TNO155 ORAL EN PACIENTES ADULTOS CON TUMORES SÓLIDOS AVANZADOS. Novartis Farmacéutica, S.A. Budget: 233522. 2018- . PI: Gil Martin, Marta.
- 18PSJ022. Targeting the most aggressive type of endometrial carcinoma. Asociación Española Contra el Cáncer (AECC). Budget: 203000. 2018-2024. PI: Matías-Guiu Guia, Xavier.